Aripiprazole Increases the PKA Signalling and Expression of the GABAA Receptor and CREB1 in the Nucleus Accumbens of Rats (Q48234174)

9 February 2018

title

Aripiprazole Increases the PKA Signalling and Expression of the GABAA Receptor and CREB1 in the Nucleus Accumbens of Rats (English)

1 reference

9 February 2018

1 reference

3

1 reference

9 February 2018

Chao Deng

series ordinal

4

1 reference

9 February 2018

Bo Pan

object named as

Bo Pan

series ordinal

1

0 references

Jiamei Lian

object named as

Jiamei Lian

series ordinal

2

0 references

publication date

19 February 2016

1 reference

9 February 2018

Journal of Molecular Neuroscience

published in

1 reference

9 February 2018

volume

59

1 reference

9 February 2018

issue

1

1 reference

9 February 2018

page(s)

36-47

1 reference

9 February 2018

In vivo occupancy of dopamine D2 receptors by antipsychotic drugs and novel compounds in the mouse striatum and olfactory tubercles

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Uncoupling of GABA(A) and benzodiazepine receptor binding activity in the hippocampal formation of schizophrenic brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Dopamine agonists in schizophrenia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Efficacy and safety of bifeprunox in patients with an acute exacerbation of schizophrenia: results from a randomized, double-blind, placebo-controlled, multicenter, dose-finding study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Metabotropic regulation of extrasynaptic GABAA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

cAMP response element-binding protein is activated by Ca2+/calmodulin- as well as cAMP-dependent protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Different effects of bifeprunox, aripiprazole, and haloperidol on body weight gain, food and water intake, and locomotor activity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Changes in serotonin2A and GABA(A) receptors in schizophrenia: studies on the human dorsolateral prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Increased density of GABAA receptors in the superior temporal gyrus in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Differential effects of short- and long-term antipsychotic treatment on the expression of neuregulin-1 and ErbB4 receptors in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Differential effects of haloperidol and clozapine on [(3)H]cAMP binding, protein kinase A (PKA) activity, and mRNA and protein expression of selective regulatory and catalytic subunit isoforms of PKA in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Drugs in development for the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Role of dopamine D(2) receptors for antipsychotic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: implications for long-term drug efficacy and low extrapyramidal side-effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Two classes of cortical GABA neurons defined by differential calcium binding protein immunoreactivities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

The dopamine hypothesis of schizophrenia: version III--the final common pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Immunohistochemical and immunoblot study of GABA(A) alpha1 and beta2/3 subunits in the prefrontal cortex of subjects with schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Clozapine induces chloride channel-4 expression through PKA activation and modulates CDK5 expression in SH-SY5Y and U87 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Effect of haloperidol on cyclic AMP and inositol trisphosphate in rat striatum in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Half a century of antipsychotics and still a central role for dopamine D2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Developmental vitamin D deficiency alters MK 801-induced hyperlocomotion in the adult rat: An animal model of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Haloperidol-induced Fos expression in striatum is dependent upon transcription factor cyclic AMP response element binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Mitogen-activated protein kinases in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Antipsychotic properties of the partial dopamine agonist (-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine(preclamol) in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Betahistine ameliorates olanzapine-induced weight gain through modulation of histaminergic, NPY and AMPK pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Betahistine co-treatment ameliorates dyslipidemia induced by chronic olanzapine treatment in rats through modulation of hepatic AMPKα-SREBP-1 and PPARα-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Aripiprazole: dose-response relationship in schizophrenia and schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Treatment with haloperidol and diazepam alters GABA(A) receptor density in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

The hippocampus and nucleus accumbens as potential therapeutic targets for neurosurgical intervention in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Dose determination of haloperidol, risperidone and olanzapine using an in vivo dopamine D2-receptor occupancy method in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Unique Effects of Acute Aripiprazole Treatment on the Dopamine D2 Receptor Downstream cAMP-PKA and Akt-GSK3β Signalling Pathways in Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Benzodiazepine receptors in the post-mortem brain of suicide victims and schizophrenic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Differential effects of amisulpride and haloperidol on dopamine D2 receptor-mediated signaling in SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Aripiprazole differentially regulates the expression of Gad67 and γ-aminobutyric acid transporters in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Opposite regulation by typical and atypical anti-psychotics of ERK1/2, CREB and Elk-1 phosphorylation in mouse dorsal striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Dose translation from animal to human studies revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

The effects of antipsychotic drugs on GABAA receptor binding depend on period of drug treatment and binding site examined

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Evolutionary paths of the cAMP-dependent protein kinase (PKA) catalytic subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Reduced [3H]flunitrazepam binding in cingulate cortex and hippocampus of postmortem schizophrenic brains: is selective loss of glutamatergic neurons associated with major psychoses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

In vitro pharmacology of aripiprazole, its metabolite and experimental dopamine partial agonists at human dopamine D2 and D3 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Differences in agonist/antagonist properties at human dopamine D(2) receptors between aripiprazole, bifeprunox and SDZ 208-912.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Aripiprazole's low intrinsic activities at human dopamine D2L and D2S receptors render it a unique antipsychotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Dopamine D2 and serotonin 5-HT1A receptors mediate the actions of aripiprazole in mesocortical and mesoaccumbens transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Striatal dopamine-2 receptor occupancy as measured with [123I]iodobenzamide and SPECT predicted the occurrence of EPS in patients treated with atypical antipsychotics and haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Antipsychotics regulate cyclic AMP-dependent protein kinase and phosphorylated cyclic AMP response element-binding protein in striatal and cortical brain regions in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Functional Selectivity and Classical Concepts of Quantitative Pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

The ins and outs of the striatum: role in drug addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Phosphorylation of ERK and CREB in cultured hippocampal neurons after haloperidol and risperidone administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Differential effects of long-term treatment with clozapine or haloperidol on GABAA receptor binding and GAD67 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Abnormal Levels of cAMP-dependent Protein Kinase Regulatory Subunits in Platelets from Schizophrenic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-016-0730-Y

Evidence for a second isoform of the catalytic subunit of cAMP-dependent protein kinase

21 January 2018

1 reference

12 December 2020

The cAMP-dependent protein kinases and cAMP signal transduction.

1 reference

12 December 2020

Novel variants in the promoter region of the CREB gene in schizophrenic patients

1 reference

12 December 2020

7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity.

1 reference

12 December 2020

The GABA system in schizophrenia: cells, molecules and microcircuitry

1 reference

12 December 2020

Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics

1 reference

12 December 2020

[3H]muscimol binding sites increased in autopsied brains of chronic schizophrenics

1 reference

12 December 2020

Distinct patterns of cAMP-dependent protein kinase gene expression in mouse brain

1 reference

12 December 2020

Modulation of synaptic GABAA receptor function by PKA and PKC in adult hippocampal neurons

1 reference

12 December 2020

10.1007/S12031-016-0730-Y

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018